A Phase II, Multicenter, Open-label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or Are Intolerant to First-line Platinum-Based Chemotherapy

Name: A Phase II, Multicenter, Open-label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or Are Intolerant to First-line Platinum-Based Chemotherapy
Creator: Vivli
Published: 2026-04-29 20:35:25
License: 暂无描述

DataCite Commons2026-04-29 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00013058/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The study to evaluate M7824 monotherapy in participants with advanced or metastatic biliary tract cancer (BTC) who failed or were intolerant to first-line (1L) chemotherapy.

提供机构：

Vivli

创建时间：

2026-04-29